Skip to main content
Premium Trial:

Request an Annual Quote

InDevR to Develop Influenza Assay with CDC

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life sciences assay developer InDevR is collaborating with researchers at the US Centers for Disease Control and Prevention's Influenza Division to develop a microarray assay for use in influenza virus screening.

Boulder, Colo.-based InDevR will work with CDC scientists as a subcontractor to develop a low-density microarray that can screen influenza viruses for genetic reassortment. The company said that the array will enable point-of-service screening to track the emergence of viruses like the swine origin H1N1, in which genetic mixing occurred between influenza viruses that were adapted to different species.

Development of the microarray, which will be coupled with InDevR's ampliPHOX system, is being funded by a two-year, internal CDC grant.

The new collaboration with CDC "will leverage our combined experience with low-density microarray development, CDC's expertise in influenza surveillance, and InDevR's new ampliPHOX colorimetric detection technology," InDevR Co-founder and CEO Kathy Rowlen said in a statement.

Rowlen said that the microarray technology "could greatly enhance global influenza surveillance efforts," which will "provide essential time-critical information for vaccine preparation."

Financial terms of the contract were not immediately available.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.